MedTrace Logo

Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure

NCT02926703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2016-10-07

No results posted yet for this study

Summary

The investigators compared the feasibility of serum creatine kinase and serum lactate concentration as diagnostic markers to distinguish between generalized tonic-clonic seizures (GTCS) and syncopes in clinical settings that require fast-action treatment, such as in the emergency departments.

Conditions

  • Seizure
  • Syncope

Interventions

OTHER

Serum lactate and CK concentrations in blood samples

Serum lactate and CK concentrations in blood samples were measured routinely at admission

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Manuel Dafotakis, Dr. · Department of Neurology, University Hospital RWTH Aachen, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02926703 on ClinicalTrials.gov